MwanzoDMN • FRA
add
Diamyd Medical AB
Bei iliyotangulia
€ 0.078
Bei za siku
€ 0.085 - € 0.085
Bei za mwaka
€ 0.075 - € 1.80
Thamani ya kampuni katika soko
210.56M SEK
Wastani wa hisa zilizouzwa
elfu 2.31
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
STO
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (SEK) | Feb 2026info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 99.00 | 15.12% |
Matumizi ya uendeshaji wa biashara | 64.34M | 43.95% |
Mapato halisi | -62.88M | -40.14% |
Kiwango cha faida halisi | elfu -63.51 | -21.74% |
Mapato kwa kila hisa | — | — |
EBITDA | -63.24M | -43.70% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (SEK) | Feb 2026info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 190.73M | 83.83% |
Jumla ya mali | 253.63M | 40.22% |
Jumla ya dhima | 83.84M | 20.89% |
Jumla ya hisa | 169.80M | — |
hisa zilizosalia | 137.50M | — |
Uwiano wa bei na thamani | 0.06 | — |
Faida inayotokana na mali | -58.47% | — |
Faida inayotokana mtaji | -80.99% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (SEK) | Feb 2026info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -62.88M | -40.14% |
Pesa kutokana na shughuli | -39.51M | 18.40% |
Pesa kutokana na uwekezaji | -20.11M | -4,291.05% |
Pesa kutokana na ufadhili | -2.14M | -237.01% |
Mabadiliko halisi ya pesa taslimu | -62.39M | -27.00% |
Mtiririko huru wa pesa | -19.53M | 40.32% |
Kuhusu
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1984
Tovuti
Wafanyakazi
41
